Pinpoint secures new investment to develop "ground-breaking" products

29 Nov 2019

The financial backing will help the company to develop a new generation of microbial air monitors that enables continuous monitoring as demanded by the Annex 1 revision.

Pinpoint Scientific, specialist product designers and manufacturers of environmental monitoring solutions for the pharmaceutical and related industries, has secured further investment into the business, to aid the development of its ImpactAir range of environmental monitoring solutions.

Pinpoint secures new investment to develop ground-breaking products
ImpactAir microbial air samplers developed by Pinpoint Scientific.

Cherwell Laboratories and Development Bank of Wales (DBW) have both invested in Pinpoint and taken a minority share in the business. The investment not only secures jobs in South Wales, a key objective of DBW, but also allows the business to bring to the market some exciting new products within the ImpactAir range. Cherwell is an existing distributor of ImpactAir products within the UK and Andy Whittard, Cherwell’s Managing Director, has also taken a seat on the Pinpoint board to help with business strategy and planning.

Gethin Jones, Managing Director of Pinpoint and the designer of the ImpactAir product said: “This is an exciting time for Pinpoint. We have been working on very innovative ideas to develop a new generation of microbial air monitors to meet the new pharmaceutical regulations. This investment is perfect timing for Pinpoint and allows us to create a range of ground-breaking products for this market.”

Andy Whittard added: “I am really excited to join up with Gethin and the team at Pinpoint to help create an exciting range of products for pharma EM. The Annex 1 revision is potentially going to shift the dynamics for EM within grade A spaces and I think Pinpoint is well placed to service that need with innovative and highly effective monitoring devices.”

Sarah Smith, Investment Executive with the Technology Venture Investment team at the DBM said: “Our Wales Technology Seed Fund provides businesses like Pinpoint with the funding that they need to further develop their products. Together with Cherwell Laboratories, we will work with the team to support their growth in this niche sector as providers of continuous air quality for life science cleanrooms. This is an exciting time for the team as they look to capitalise on their existing customer base and scale the business. We wish them every success.”

The ImpactAir range of microbial air samplers is shortly to be expanded with the introduction of the new ImpactAir ISO-90 Monitoring Platform. ImpactAir is designed for continuous monitoring in high-grade areas, where in-process sampling of viable particles is often critical. The ImpactAir ISO is a modular system designed to integrate into isolators or RABS, using an external controller and local or remotely located air mover. It can be designed in almost any orientation using standard or custom-made connections. The ISO-90-Monitoring Head features a chamber for 90-mm agar plates and a highly efficient slit to agar sampling method. The low D50 value and ability to sample for long periods makes the ISO-90 ideal for continuous monitoring as demanded by the Annex 1 revision.

Read More

Related news

FDA success for MedPharm Centre of Excellence

FDA success for MedPharm Centre of Excellence

14 Feb 2020

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

Read more 
Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing

Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing

12 Feb 2020

Partnership will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Read more 
Catalent to manufacture first-in-class mAb targeting solid tumours

Catalent to manufacture first-in-class mAb targeting solid tumours

11 Feb 2020

ZM008 could have potential benefits for the treatment of prostate cancer.

Read more 
BD completes clinical trial for its wearable injector

BD completes clinical trial for its wearable injector

11 Feb 2020

The pre-filled, pre-assembled injector is designed to prioritize safety, convenience and usability while delivering high-value drug treatments in the comfort of an in-home environment.

Read more 
Innovation awarded at Pharmapack

Innovation awarded at Pharmapack

10 Feb 2020

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Read more 
2020 - a year for 'big answers' rather than 'big data'

2020 - a year for 'big answers' rather than 'big data'

7 Feb 2020

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

Read more 
Recipharm acquisition to make it a top 5 global CDMO?

Recipharm acquisition to make it a top 5 global CDMO?

6 Feb 2020

CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.

Read more 
New Velesco Pharma clinical manufacturing facility begins operations

New Velesco Pharma clinical manufacturing facility begins operations

5 Feb 2020

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

Read more 
Colorcon starts No-Tox ink manufacturing at new UK facility

Colorcon starts No-Tox ink manufacturing at new UK facility

4 Feb 2020

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Read more 
Hovione announces key patent grants for its large dose DPI

Hovione announces key patent grants for its large dose DPI

4 Feb 2020

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

Read more